Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acetaminophen (APAP) overdose is the leading cause of acute liver failure in the US. Although substantial progress regarding the mechanisms of APAP hepatotoxicity has been made in the past several decades, therapeutic options are still limited and novel treatments are clearly needed. c-jun N-terminal Kinase (JNK) has emerged as a promising therapeutic target in recent years. AREAS COVERED: Early studies established the critical role of JNK activation and mitochondrial translocation in APAP hepatotoxicity. However, this concept has also been challenged. Initial studies failed to reproduce the protection of JNK deficiency in APAP toxicity and concerns over off-target effects of JNK inhibitors and even in knock-out mice are increasing. Interestingly, recent studies have even shown that liver injury can be altered with or without effects on JNK activation. The current review addresses these discrepancies and tries to explain or reconcile some of the conflicting results. EXPERT OPINION: JNK is a potential therapeutic target for APAP poisoning. However, controversies still exist regarding its actual role in APAP hepatotoxicity. Future studies are warranted for more in-depth testing of specific inhibitors in well-defined preclinical models and human hepatocytes before JNK can be considered a relevant therapeutic target for APAP poisoning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 3×
“0 μM) [37], we cannot exclude the possibility that inhibition of other kinases by SP600125 may contribute or even be responsible for the effect, especially since the dose of SP600125 used was ‡ 10 mg/kg and the actual cellular concentrations of the inhibitor in vivo were unknown [25,26,30,40,41].”
BackgroundMethodMammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102 · cited 1×
“As a result, NAC has to be given shortly after APAP overdose, before the early metabolism phase is complete, to achieve its greatest effect (within 24 h of overdose in humans) [19,20].”
BackgroundHanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708916200 · Cited by 527
C-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
Saito, C., Zwingmann, C., & Jaeschke, H. (2010) · Hepatology · doi:10.1002/hep.23267 · Cited by 430 · cited 1×
“Dependent on the time of NAC administration, its protective mechanisms include promoting GSH biosynthesis to scavenge NAPQI, detoxifying reactive oxygen species and peroxynitrite, and serving as a Krebs cycle intermediate to support mitochondrial energy production [11,16-18].”
BackgroundSelf-citationCover, C., Mansouri, A., Knight, T. R., Bajt, M. L., Lemasters, J. J., Pessayre, D., & Jaeschke, H. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088898 · Cited by 373
Self-citationWin, S., Than, T. A., Han, D., Petrovic, L. M., & Kaplowitz, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276089 · Cited by 197 · cited 2×
“The authors also provided evidence that RIP1 translocates to the mitochondria independent of the anchor protein Sab (SH3 domain-binding protein that preferentially associates with Btk), which is a mandatory mitochondrial anchor for JNK [78].”
BackgroundIdentification of a new JNK inhibitor targeting the JNK-JIP interaction site
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805677105 · Cited by 186 · cited 1×
“Intriguingly, various JNK inhibitors have been discovered and some of them, such as SP600125 and D-JNKI1, have demonstrated effectiveness in preclinical studies, and CC-930 has even gone into clinical trial [22,92-94].”
Background
Cited by
Du, K., Ramachandran, A., & Jaeschke, H. (2016) · Redox Biology · doi:10.1016/j.redox.2016.10.001 · Cited by 569
Self-citationAcetaminophen from liver to brain: New insights into drug pharmacological action and toxicity
Ghanem, C. I., Pérez, M. J., Manautou, J. E., & Mottino, A. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.020 · Cited by 384
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
Guo, K., & van den Beucken, T. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01317-2 · Cited by 28
Metadata
- Authors
- Du, K., Xie, Y., McGill, M. R., & Jaeschke, H.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2015-07-20
- Volume
- 11
- Issue
- 11
- Pages
- 1769-1779
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W1840223240
- Cited by
- 67
- References
- 10
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity. https://app.cochat.ai/papers/10.1517/17425255.2015.1071353
- The paper
- Du, K., Xie, Y., McGill, M. R., & Jaeschke, H. (2015). Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425255.2015.1071353
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.